Skip to main content
22 December 2024
Last updated:
Sunday 22 December 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Developing radionuclide PARP inhibitors
Read more
The linker matters in antibody-drug conjugates
Read more
Real world evidence is changing regulatory policy
Read more
The hunt for the perfect tumour-associated antigen
Read more
New treatments for amyotrophic lateral sclerosis
Read more
Using wastewater surveillance to control Covid-19
Read more
Transatlantic partnerships in life science
Read more
The role of antibodies in Covid-19 treatment
Read more
Oncology approvals are on an upward trend
Read more
Finding a link between the microbiome and disease
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
16
Page
17
Page
18
Page
19
Current page
20
Page
21
Page
22
Page
23
Page
24
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
